|
Re: Novartis' canakinumab (Ilaris)
|
7
|
Resverlogix Corp.
|
Mar 13, 2018 03:20PM
|
|
Key Dates Over the Next Four Months
|
7
|
Resverlogix Corp.
|
Jul 19, 2019 06:27PM
|
|
Re: Equity financing
|
7
|
Zenith Epigenetics
|
Jun 07, 2018 05:03PM
|
|
Re: Apabetalone......a Calculated Risk
|
7
|
Resverlogix Corp.
|
Apr 07, 2019 07:16AM
|
|
Re: Could there be another shoe waiting to drop?
|
7
|
Resverlogix Corp.
|
May 20, 2019 07:22AM
|
|
ZEN-3694 synergy with enzalutamide and PARP inhibitors
|
7
|
Zenith Epigenetics
|
Aug 09, 2019 11:19AM
|
|
Re: Zenith MD&A and Financials are up
|
7
|
Zenith Epigenetics
|
Oct 28, 2019 03:36PM
|
|
Re: Zenith Epigenetics Corp. Commences Operations
|
7
|
Zenith Epigenetics
|
Dec 09, 2015 04:44PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
7
|
Resverlogix Corp.
|
Mar 24, 2020 12:51PM
|
|
Re: Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer
|
7
|
Zenith Epigenetics
|
Nov 20, 2018 10:29AM
|
|
Re: What else can RVX treat that we don’t know about yet?
|
7
|
Resverlogix Corp.
|
Mar 31, 2019 04:01PM
|
|
Compilation of BET inhibitor Trials
|
7
|
Resverlogix Corp.
|
Oct 05, 2017 01:13PM
|
|
Re: Newbie
|
7
|
Resverlogix Corp.
|
Apr 14, 2019 09:02PM
|
|
Re: COVID-19 and BRD4: a stormy and cardiotoxic bromo-romance
|
7
|
Resverlogix Corp.
|
Dec 14, 2021 01:53PM
|
|
Re: Total (MACE) Events?
|
7
|
Resverlogix Corp.
|
Jun 18, 2017 11:13PM
|
|
Re: Brilanta-AZ
|
7
|
Resverlogix Corp.
|
Apr 19, 2018 10:18AM
|
|
Link for tomorrow morning late breaker results
|
7
|
Resverlogix Corp.
|
Nov 15, 2019 02:33PM
|
|
Re: Zenith share issue
|
7
|
Zenith Epigenetics
|
Nov 14, 2017 12:47PM
|
|
Re: Question to ask at the AGM
|
7
|
Resverlogix Corp.
|
Oct 30, 2019 11:30AM
|
|
Q4 Events List Updated
|
7
|
Resverlogix Corp.
|
Oct 19, 2015 10:37AM
|
